IP Library Granted Patent US 7,960,341
Granted Patent B2
US 7,960,341 · App. 11/518,574 · Granted Jun 14, 2011

Methods and compositions for treating polycystic ovary syndrome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,341
App. No.
11/518,574
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.

Claims (19)

1. A method for treating polycystic ovary syndrome in a patient in need thereof comprising administering to the patient a therapeutically effective amount of

(i) an exendin-4 comprising the amino acid sequence of SEQ ID NO:9, and

(ii) metformin,

to treat the polycystic ovary syndrome in the patient.

2. The method of claim 1 , wherein the method reduces insulin resistance in the patient.

3. The method of claim 1 , wherein the method prevents the onset of type-2 diabetes in the patient.

4. The method of claim 1 , wherein the method restores regular menses in the patient.

5. The method of claim 1 , wherein the method restores regular ovulation in the patient.

6. The method of claim 1 , wherein the method restores fertility in the patient.

7. The method of claim 1 , wherein the method prevents spontaneous abortion in the patient.

8. A method for treating irregular menses in a patient diagnosed with polycystic ovary syndrome comprising administering to the patient a therapeutically effective amount of

(i) an exendin-4 comprising the amino acid sequence of SEQ ID NO:9, and

(ii) metformin,

to treat irregular menses in the patient.

9. A method for treating infertility in a patient diagnosed with polycystic ovary syndrome comprising administering to the patient a therapeutically effective amount of

(i) an exendin-4 comprising the amino acid sequence of SEQ ID NO:9, and

(ii) metformin,

to treat the infertility in the patient.

10. The method of claim 9 , wherein the method for treating infertility restores regular ovulation in the patient.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: AMYLIN PHARMACEUTICALS, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 027192/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2011
From: BEELEY, NIGEL R.A.; PRICKETT, KATHRYN S.; YOUNG, ANDREW A.; HATHAWAY, DAVID R.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 026031/0759 →